MAFK (C-Term) Antikörper

Antigen: MAFK

Epitope: C-Term

Klonalität: Polyklonal

Wirt: Kaninchen

Reaktivität: Human

Applikation: Western Blot (WB), Immunhistochemie (IHC), ELISA

Zertifikate: ISO 9001:2008

Produktnummer: ABIN390155

Produktbeschreibung

Produktmerkmale: Purified Rabbit Polyclonal Antibody (Pab)

Weitere Bezeichnung: MAFK (C-term)

Gen-ID: 7975

Swiss-Prot: NP_002351

Immunogen: This MAFK antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 539~568 amino acids from the C-terminal region of human MAFK.

Isotyp: Ig  (Passende Sekundärantikörper)

Beschreibung: Other names: MAFK

Spezifität: This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the C-terminal region of human MAFK.

Molekulargewicht: 63633 DA

Anwendungen

Applikationshinweise: The suggested dilution will be: ELISA~~1:1,000 Western blotting~~1:100~1:500 Immunohistochemistry~~1:50~100

Konzentration: 0.25 mg/ml

Reinigung: Purified

Buffer: Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS.

Lagerung: Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles

Forschungsgebiet: Krebs, Zellzyklus, Zellstruktur

Beschränkungen: Nur für Forschungszwecke einsetzbar

Bilder

Formalin-fixed and paraffin-embedded human cancer tissue reacted with the primary antibody, which was peroxidase-conjugated to the secondary antibody, followed by AEC staining. This data demonstrates the use of this antibody for immunohistochemistry. clinical relevance has not been evaluated. BC = breast carcinoma. HC = hepatocarcinoma.

The anti-MAFK Pab (ABIN390155) is used in Western blot to detect MAFK in Jurkat cell lysate.

Publikationen

Publikationen: Bennett, Romigh, Eng: "Disruption of transforming growth factor-beta signaling by five frequently methylated genes leads to head and neck squamous cell carcinoma pathogenesis." in: Cancer research, Vol. 69, Issue 24, pp. 9301-5, 2009 (PubMed).